| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and cash equivalents | $176.5M+4.9% | $168.2M+103.8% | $82.5M |
| Prepaid expenses and other current assets | $1.2M+11.4% | $1.1M-61.0% | $2.8M |
| Total current assets | $177.7M+4.9% | $169.3M+98.3% | $85.4M |
| Restricted cash | $500K+0.0% | $500K | $0 |
| Property and equipment, net | $1.9M-29.8% | $2.7M+141.0% | $1.1M |
| Operating right-of-use asset | $4.3M-15.4% | $5.0M | $0 |
| Other assets | $338K+8350.0% | $4K-96.9% | $131K |
| Total assets | $184.7M+4.0% | $177.5M+104.9% | $86.6M |
| Accounts payable | $1.9M+18.9% | $1.6M+47.0% | $1.1M |
| Accrued expenses and other current liabilities | $8.9M+5.1% | $8.4M+85.8% | $4.5M |
| Term loan, current | $585K | $0 | — |
| Total current liabilities | $11.3M+13.2% | $10.0M+78.4% | $5.6M |
| Term loan, non-current | $16.2M+57.7% | $10.3M+4.0% | $9.9M |
| Convertible Grant Agreement | $2.2M+70.8% | $1.3M | $0 |
| Lease liability, long-term | $3.8M-15.3% | $4.5M | $0 |
| Total liabilities | $33.5M+28.6% | $26.1M+55.0% | $16.8M |
| Common stock (par value $0.0001), 500,000 shares authorized; 31,924 and 26,987 shares issued and outstanding as of December 31, 2025 and 2024 | $3K+0.0% | $3K | $0 |
| Additional paid-in capital | $352.8M+21.7% | $290.0M+5297.5% | $5.4M |
| Accumulated deficit | -$201.6M-45.7% | -$138.4M-79.8% | -$77.0M |
| Accumulated other comprehensive loss | $22K+121.8% | -$101K-27.8% | -$79K |
| Total stockholders’ equity | $151.1M-0.2% | $151.5M+311.3% | -$71.7M |
| Total liabilities and stockholders’ equity | $184.7M+4.0% | $177.5M+104.9% | $86.6M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.